Press Room

Quanticate will be exhibiting at the PhUSE Annual Conference  2017, October 8th-11th, 2017, Edinburgh, Scotland. Meet us at Edinburgh International Conference Centre at booth #43

Quanticate, a global data-focused clinical research organisation (CRO), is further expanding its service offering into India with the opening of a new office.

Strategically located in Bangalore, with access to the country’s extensive talent pool in the pharmaceutical services industry, the new office will be a base from which Quanticate will broaden its capabilities for the management, analysis and reporting of data from clinical trials and post-marketing surveillance.

Quanticate will be exhibiting at the OCT New England 2017 Conference, September 6th-7th, 2017, Boston, MA. Meet us at the Westin Boston Waterfront stand #001

During May 2017, the European Commission and EMA published a Notice to marketing authorisation holders of centrally authorised medicines products for human and veterinary use, stating: “The United Kingdom submitted on 29 March 2017 the notification of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union. This means that unless the withdrawal agreement establishes another date or the period is extended by the European Council in accordance with Article 50(3) of the Treaty on European Union, all Union primary and secondary law ceases to apply to the United Kingdom from 30 March 2019, 00:00h (CET). The United Kingdom will then become a 'third country'.”

Quanticate has completed an investment initiative to upgrade its pharmacovigilance safety database and its in-house technology platform in preparation for the upcoming Article 2(3) of Directive 2010/84/EU that will impact the pharmaceutical industry later this year.

We are pleased to announce we will be exhibiting at the DIA 2017 Annual Meeting, Chicago, IL. 19 - 21 June 2017 at the McCormick Place, 2301 South Martin Luther King Jr. Drive. Meet our team at stand #509

LONDON (UK) - Quanticate, a leading global data-focused clinical research organization (CRO), today announced that it has named Praveen Dass as the company's Country Head for Indian Operations and VP of Clinical Data Management. Praveen will lead Quanticate's Operations in India to help build and expand the company’s operational center of excellence in Bangalore, India that supports outstanding customer service for Quanticate’s global clientele.

We are pleased to announce we will be exhibiting at Outsourcing in Clinical Trials, West Coast, 22 - 23 February 2017 at the Hyatt Regency San Francisco Airport Hotel, Burlingame.

We are pleased to announce we will be exhibiting at Partnerships in Clinical Trials, Europe, 16th - 17th November 2016 at the Reed Messe Wien Congress Center, Vienna.

Quanticate, a leading global data-focused Clinical Research Organization (CRO), today announced that it has named Alan Morgan as the company's Chief Operating Officer. Reporting to Quanticate's Chairman and Chief Executive Officer David Underwood, Morgan will work across Quanticate's  global office network (UK, US, India, South Africa, and Poland) to build and expand upon the company’s reputation for outstanding customer service and expertise across clinical data services.